1 |
Lemasters, J. J., Nieminen, A. L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A. and Brenner, D. A., et al. 1998. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta. 1366, 177-196.
DOI
|
2 |
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K. and Pintus, G. 2020. Potential adverse effects of resveratrol: a literature review. Int. J. Mol. Sci. 21, 2084.
DOI
|
3 |
Shetty, A. K. 2011. Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol. Ther. 131, 269-286.
DOI
|
4 |
Walker, M. C. 2018. Pathophysiology of status epilepticus. Neurosci. Lett. 667, 84-91.
DOI
|
5 |
Wu, Q. J. and Tymianski, M. 2018. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol. Brain 11, 15.
DOI
|
6 |
Marks, G. S. 1994. Heme oxygenase: the physiological role of one of its metabolites, carbon monoxide and interactions with zinc protoporphyrin, cobalt protoporphyrin and other metalloporphyrins. Cell Mol. Biol. 40, 863-870.
|
7 |
Song, X., Jensen, M. O., Jogini, V., Stein, R. A., Lee, C. H., Mchaourab, H. S., Shaw, D. E. and Gouaux, E. 2018. Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature 556, 515-519.
DOI
|
8 |
Yang, Q., Wang, B., Zang, W., Wang, X., Liu, Z., Li, W. and Jia, J. 2013. Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 8, e70627.
DOI
|
9 |
Bastianetto, S. and Quirion, R. 2010. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp. Neurol. 225, 237-239.
DOI
|
10 |
Quincozes-Santos, A. and Gottfried, C. 2011. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann. N. Y. Acad. Sci. 1215, 72-78.
DOI
|
11 |
Chaturvedi, R. K. and Flint, B. M. 2013. Mitochondrial diseases of the brain. Free Radic. Biol. Med. 63, 1-29.
DOI
|
12 |
Chen, J. 2014. Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications. Rev. Neurosci. 25, 269-280.
DOI
|
13 |
Fukui, M., Choi, H. J. and Zhu, B. T. 2010. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 49, 800-813.
DOI
|
14 |
Johnson, K. A, Conn, P. J. and Niswender, C. M. 2009. Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol. Disord. Drug Targets 8, 475-491.
DOI
|
15 |
Kim, T. H., Park, J. H. and Woo, J. S. 2919. Resveratrol induces cell death through ROS dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells. Mol. Med. Rep. 19, 3353-3360.
|
16 |
Kumar, A., Naidu, P. S., Seghal, N. and Padi, S. S. 2007. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79, 17-26.
DOI
|
17 |
Lee, J. G., Yon, J. M., Lin, C., Jung, A. Y., Jung, K. Y. and Nam, S. Y. 2012. Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons. Food Chem. Toxicol. 50, 3877-3885.
DOI
|
18 |
Lin, X., Wu, G., Huo, W. Q., Zhang, Y. and Jin, F. S. 2012. Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells. Int. J. Urol. 19, 757-764.
DOI
|
19 |
Lu, X., Ma, L., Ruan, L., Kong, Y., Mou, H., Zhang, Z., Wang, Z., Wang, J. M. and Le, Y. 2010. Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J. Neuroinflammation 7, 46.
DOI
|
20 |
Low, I. C., Chen, Z. X. and Pervaiz, S. 2010. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid. Redox Signal 13, 807-819.
DOI
|
21 |
Lyman, G. E. and DeVincenzo, J. P. 1967. Determination of picogram amounts of ATP using the luciferin-luciferase enzyme system. Anal. Biochem. 21, 435-443.
DOI
|
22 |
Marks, G. S. 1994. Heme oxygenase: the physiological role of one of its metabolites, carbon monoxide and interactions with zinc protoporphyrin, cobalt protoporphyrin and other metalloporphyrins. Cell Mol. Biol. (Noisy-le-grand) 40, 863-870.
|
23 |
Montal, M. 1998. Mitochondria, glutamate neurotoxicity and the death cascade. Biochim. Biophys. Acta 1366, 113-126.
DOI
|
24 |
Morgan, D. M. 1998. Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol. Biol. 79, 179-183.
|
25 |
Neuzil, J. and Stocker, R. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269, 16712-16719.
DOI
|
26 |
Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R. and Brown, A. L., et al. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433.
DOI
|
27 |
Pervaiz, S. 2003. Resveratrol: from grapevines to mammalian biology. FASEB J. 17, 1975-1985.
DOI
|
28 |
Reiner, A. and Levitz, J. 2018. Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert. Neuron 98, 1080-1098.
DOI
|
29 |
Fukui, M., Choi, H. J. and Zhu, B. T. 2010. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 49, 800-813.
DOI
|
30 |
Cassano, T., Pace, L., Bedse, G., Lavecchia, A. M., De Marco, F., Gaetani, S. and Serviddio, G. 2016. Glutamate and Mitochondria: Two prominent Players in the oxidative stress-induced neurodegeneration. Curr. Alzheimer Res. 13, 185-197.
DOI
|
31 |
Khatri, N., Thakur, M., Pareek, V., Kumar, S., Sharma, S. and Datusalia, A. K. 2018. Oxidative stress: major threat in traumatic brain injury. CNS Neurol. Disord. Drug Targets 17, 689-695.
DOI
|
32 |
Lai, T. W, Shyu, W. C. and Wang, Y. T. 2011. Stroke intervention pathways: NMDA receptors and beyond. Trends Mol. Med. 17, 266-275.
DOI
|
33 |
Rolo, A. P. and Palmeira, C. M. 2006. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 212, 167-178.
DOI
|
34 |
Springer, M. and Moco, S. 2019. Resveratrol and its human metabolites-effects on metabolic health and obesity. Nutrients 11, 143.
DOI
|
35 |
Wang, R. and Reddy, P. H. 2017. Role of glutamate and NMDA receptors in Alzheimer's disease. J. Alzheimers Dis. 57, 1041-1048.
DOI
|
36 |
Zhou, X., Chen, Z., Yun, W., Ren, J., Li, C. and Wang, H. 2015. Extrasynaptic NMDA receptor in excitotoxicity: function revisited. Neuroscientist 21, 337-344.
DOI
|